Harald Enzmann - Concepedia

Author

Harald Enzmann

Federal Institute for Drugs and Medical Devices

Also Known As

Enzmann H, H Enzmann, H. Enzmann, H.G. Enzmann, Harald Enzmann, Harald G Enzmann, Harald G. Enzmann

137

Publications

1.8K

Citations

H-Index

Concepts

All Affiliations

Federal Institute for Drugs and Medical Devices German Cancer Research Center DKFZ-ZMBH Alliance European Medicines Agency New York Medical College

About

Harald Enzmann is an author at Federal Institute for Drugs and Medical Devices specializing in medicine, pharmacology, and pathology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	12	15	412
2	Allergy	5	5	114
3	Health Sciences	3	3	75
4	Allergy Medicine	2	2	48
5	Engineering	1	1	12

Harald Enzmann

Publications

884

Citations

H-Index

Page 1

	Year	Citations
Analysis of signaling pathways related to cell proliferation stimulated by insulin analogs in human mammary epithelial cell lines Ashish Shukla, Jean Grisouard, Volker Ehemann, Endocrine Related Cancer Human GrowthCell ProliferationCellular PhysiologyInsulin SignalingTumor Biology	2009	130
The European Medicines Agency's EU conditional marketing authorisations for COVID-19 vaccines Marco Cavaleri, Harald Enzmann, Sabine M. J. M. Straus, The Lancet	2021	101
Tigroid cell foci and neoplastic nodules in the liver of rats treated with a single dose of aflatoxin B<sub>1</sub> Peter Bannasch, U. Benner, Harald Enzmann, Carcinogenesis	1985	64
Regulators' Advice Can Make a Difference: European Medicines Agency Approval of Zynteglo for Beta Thalassemia Martina Schuessler‐Lenz, Harald Enzmann, Spiros Vamvakas Clinical Pharmacology & Therapeutics	2019	54
Proceedings of the 2016 China Cancer Immunotherapy Workshop Bin Xue, Jiaqi Xu, Wenru Song, Journal of Hematology & Oncology ImmunologyImmunoeditingImmunotherapeuticsImmune Cell TherapyT Cells	2016	52
EMA Review of Belantamab Mafodotin (Blenrep) for the Treatment of Adult Patients with Relapsed/Refractory Multiple Myeloma Kyriaki Tzogani, Karri Penttilä, Johanna Lähteenvuo, The Oncologist	2020	45
Clinical pharmacology of tyrosine kinase inhibitors becoming generic drugs: the regulatory perspective Niels Eckstein, Lea Röper, Bodo Haas, Journal of Experimental & Clinical Cancer Research	2014	40
Simple elementary method for the quantification of focal liver lesions induced by carcinogens Harald Enzmann, Lutz Edler, Peter Bannasch Carcinogenesis	1987	35
Diode laser treatment in therapy-resistant allergic rhinitis: impact on nasal obstruction and associated symptoms Philipp P. Caffier, Hans Scherer, Konrad Neumann, Lasers in Medical Science AsthmaAllergyNasal ObstructionDiode Laser TreatmentTherapy-resistant Allergic Rhinitis	2010	31
Comparative efficacy of azelastine nasal spray and terfenadine in seasonal and perennial rhinitis H Gastpar, D. Nölte, R Aurich, Allergy AsthmaAllergyNasal ObstructionPerennial RhinitisAllergy Medicine	1994	29

Page 1